comparemela.com

Latest Breaking News On - Mycrodose therapeutics - Page 2 : comparemela.com

Nova Mentis Provides Corporate Update - 2022 Planned Catalysts

/CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global leader in.

San diegoUnited statesBritish columbiaViviana trezzaAccess programmeNova mentis life science corpItalian ministry of healthNeither the canadian securities exchangeEuropean unionEuropean medicines agencyRoma tre universityHealth canadaCanadian securities exchangeMentis life scienceWill rascanDrug master file

Nova Mentis and Mycrodose Therapeutics Announce Major Milestone with Transdermal Technology for Fragile X Syndrome Clinical Program

/PRNewswire/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global leader in.

State of californiaUnited statesSan diegoBritish columbiaResearch advisory boardNova mentis life science corpUnited states drug enforcement agencyEuropean unionUs food drug administrationMentis life scienceMycrodose therapeuticsFragilex syndromeAutism spectrum disorderWill rascanChief executive officerSouthern california

Mycrodose Therapeutics Expands Scientific Advisory Board with the Addition of Dr Yavorsky and Dr Jacques

San Diego, California (Newsfile Corp. - December 14, 2021) - Mycrodose Therapeutics ("Mycrodose"), a leading US pharmaceutical company developing advanced drug delivery technologies for use with psychedelic

State of californiaUnited statesSan diegoKostenloser wertpapierhandelThorne healthtechJacqueline jacquesPatrick eckstromChristian yavorskyResearch advisory boardUnited states drug enforcement agencyMicrodosing technologyObesity societyCalifornia naturopathic doctors associationSamueli integrative health instituteObesity action coalitionCompanies of johnson

Jamaican magic mushroom breaks into Canadian market

Canadian biotechnology company Havn Life Sciences Inc has successfully exported psilocybi.

United kingdomTim mooreHealthtech connexOur nectar health sciences laboratory divisionPsilobrain therapeutics incHavn life sciencesHavn life sciences incHealth canadaJourney centersNectar health sciences laboratory divisionNew worldLife sciencesHavn lifeHavn labsHypha wellnessBritish columbia

HAVN Life Successfully Exports Psilocybin from its Jamaica Facility into Canada

/CNW/ - Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "Havn Life") a biotechnology company pursuing standardized extraction of.

United kingdomBritish columbiaTim mooreHealthtech connexOur nectar health sciences laboratory divisionHealth sciences laboratory division incCompany signs supply agreementHealth canada complianceJimmy pattison groupBritish columbia association of clinical counsellorsJourney centersNectar health sciences laboratory division incCompany or havn lifePsilobrain therapeutics incAspreva pharmaceuticalsHavn life sciences inc

vimarsana © 2020. All Rights Reserved.